TLTFFTheralase Technologies Inc.

About Theralase Technologies Inc. (TLTFF)

Theralase Technologies Inc. (TLTFF) is a Medical Devices company headquartered in Toronto, ON, Canada whose shares trade over-the-counter on the OTCQB tier.

Theralase Technologies Inc. ("Theralase" or "Company") (TSXV: TLT) (OTCQB: TLTFF) is a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds and their associated drug formulations to safely and effectively destroy various cancers. The Company in its Laser Division designs, manufactures and distributes patented and proprietary medical laser technology.

Products and services

Theralase® is a clinical stage pharmaceutical company dedicated to the research and development of light activated compounds and their associated drug formulations with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. The Company in its Anti-Cancer Therapy (“ACT”) division conducts preclinical and clinical research and development for PDCs, primarily in the treatment of cancer, with assistance from the CLT division to develop medical lasers to activate them. The Company in its Cool Laser Technology (“CLT”) division designs, develops, manufactures and markets proprietary super-pulsed laser technology indicated and cleared by Health Canada and the Food and Drug Administration (“FDA”) for the healing of chronic knee pain and when used off-label for healing numerous nerve, muscle and joint conditions.

TLTFF key facts

Ticker symbol

TLTFF

Market tier

OTCQB

Sector

Healthcare

Industry

Medical Devices

Headquarters

Toronto, ON, Canada

Country of incorporation

CA

Year of incorporation

1989

Employees

16

Estimated market cap

$35.42M (as of Apr 10, 2025)

Shares outstanding

248,814,371

Reporting standard

International Reporting: TSX Venture Exchange

Audit status

Audited

Fiscal year end

12/31

Latest filing

Interim Financial Report (Sep 30, 2024)

Theralase Technologies Inc. leadership

• Roger Dumoulin-White — President, CEO
• Kristina Hachey — CFO
• Arkady Mandel — Chief Scientific Officer

Explore more: Medical Devices stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with T